Newly identified genes associated with Erdheim-Chester disease (ECD), an ultra-rare disease, are also linked to cancer, according to a new study. Thus, ECD should be considered a type of cancer and treated by oncologists. A new clinical trial — enrolling ECD patients now — will test the use of the drugs dabrafenib and trametinib.